Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Kiniksa Pharmaceuticals, Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.46 | $0.77 | $0.14 |
| Q2 2025 | 1 | $0.18 | $0.18 | $0.18 |
| Q3 2025 | 1 | $0.16 | $0.16 | $0.16 |
| Q4 2025 | 1 | $0.23 | $0.23 | $0.23 |
| Q1 2026 | 1 | $0.41 | $0.41 | $0.41 |
| Q2 2026 | 1 | $0.50 | $0.50 | $0.50 |
| Q3 2026 | 1 | $0.50 | $0.50 | $0.50 |
| Q4 2026 | 1 | $0.47 | $0.47 | $0.47 |
Kiniksa Pharmaceuticals, Ltd. Earnings Date And Information
Kiniksa Pharmaceuticals, Ltd. last posted its earnings results on Tuesday, February 25th, 2025. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $0.06. The company had revenue of 122.54 M for the quarter and had revenue of 423.24 M for the year. Kiniksa Pharmaceuticals, Ltd. has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -31.93. Kiniksa Pharmaceuticals, Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based on prior year's report dates.
Kiniksa Pharmaceuticals, Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/25/2025 | Q4 2024 | -$0.06 | -$0.12 | -0.06 | $123.42 M | $122.54 M |
| 10/29/2024 | Q3 2024 | -$0.02 | -$0.18 | -0.16 | $111.51 M | $112.21 M |
| 07/25/2024 | Q2 2024 | N/A | -$0.06 | N/A | $90.60 M | $108.63 M |
| 04/25/2024 | Q1 2024 | N/A | -$0.25 | N/A | $76.97 M | $79.86 M |
| 02/28/2024 | Q4 2023 | -$0.11 | $0.36 | 0.47 | $73.25 M | $83.40 M |
| 11/02/2023 | Q3 2023 | N/A | -$0.20 | N/A | $64.55 M | $67.05 M |
| 08/01/2023 | Q2 2023 | N/A | $0.21 | N/A | $52.06 M | $71.47 M |
| 05/04/2023 | Q1 2023 | N/A | -$0.18 | N/A | $46.61 M | $48.35 M |
| 03/02/2023 | Q4 2022 | N/A | $0.06 | N/A | $45.12 M | $61.88 M |
| 11/03/2022 | Q3 2022 | N/A | $3.23 | N/A | $93.58 M | $99.14 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.29 | N/A | $28.42 M | $26.97 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.36 | N/A | $30.10 M | $32.19 M |
| 02/24/2022 | Q4 2021 | N/A | -$0.53 | N/A | $17.60 M | $18.75 M |
| 11/04/2021 | Q3 2021 | N/A | -$0.44 | N/A | $10.26 M | $12.10 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.61 | N/A | $4.29 M | $7.70 M |
| 05/06/2021 | Q1 2021 | N/A | -$0.72 | N/A | $7.78 M | $0 |
| 02/25/2021 | Q4 2020 | N/A | -$0.79 | N/A | N/A | $0 |
| 11/05/2020 | Q3 2020 | -$0.59 | -$0.66 | -0.07 | N/A | $0 |
| 08/04/2020 | Q2 2020 | N/A | -$0.65 | N/A | N/A | $0 |
| 05/04/2020 | Q1 2020 | N/A | -$0.48 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Kiniksa Pharmaceuticals, Ltd. Earnings: FAQ's
Kiniksa Pharmaceuticals, Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based offlast year's report dates.
The conference call for Kiniksa Pharmaceuticals, Ltd.'s latest earnings report can be listened to online.
The conference call transcript for Kiniksa Pharmaceuticals, Ltd.'s latest earnings report can be read online.
Kiniksa Pharmaceuticals, Ltd. (:KNSA) has a recorded annual revenue of $423.24 M.
Kiniksa Pharmaceuticals, Ltd. (:KNSA) has a recorded net income of $-43,193,000.Kiniksa Pharmaceuticals, Ltd. has generated $-0.6 earnings per share over the last four quarters.
Kiniksa Pharmaceuticals, Ltd. (:KNSA) has a price-to-earnings ratio of -31.93 and price/earnings-to-growth ratio is 0.08.